HUMA
Humacyte·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HUMA fundamentals
Humacyte (HUMA) released its earnings on Nov 12, 2025: revenue was 753.00K (YoY 0.00%), missed estimates; EPS was -0.11 (YoY +66.67%), beat estimates.
Revenue / YoY
753.00K
0.00%
EPS / YoY
-0.11
+66.67%
Report date
Nov 12, 2025
HUMA Earnings Call Summary for Q3,2025
- Symvess Commercial Breakthrough: 92 hospitals approved, Q3 sales surge to $703K, with first military sale.
- Clinical Excellence: 92% patency in complex cases, comparable to autologous vein, and 87% potency in combat injuries.
- Financial Resilience: $76.3M cash runway, 24% R&D reduction, and $50M+ cost savings on track.
- Strategic Focus: Dialysis BLA submission in 2026, coronary trial in 2026, and no NTAP resubmission.
EPS
Revenue
Revenue & Expenses
HUMA has released its 2025 Q3 earnings report, with revenue of 753.00K, reflecting a YoY change of NaN%, and net profit of -17.51M, showing a YoY change of 55.33%. The Sankey diagram below clearly presents HUMA's revenue sources and cost distribution.
Key Indicators
Humacyte (HUMA) key financial stats and ratios, covering profitability, financial health, and leverage.
Humacyte (HUMA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Humacyte (HUMA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Humacyte (HUMA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Humacyte (HUMA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Humacyte (HUMA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Humacyte's earnings call?What is Humacyte's latest dividend and current dividend yield?What does Humacyte do and what are its main business segments?What is the market's earnings forecast for Humacyte next quarter?What is Humacyte's gross profit margin?What guidance did Humacyte's management provide for the next earnings period?Did Humacyte beat or miss consensus estimates last quarter?What were the key takeaways from Humacyte’s earnings call?
